|
|
Article: Mayo Clinic study finds FDA warning against droperidol unnecessary.(Drug Safety)
- Article from:
- Adverse Event Reporting News
- Article date:
- October 8, 2007
CopyrightCOPYRIGHT 2007 Washington Information Source, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
A Mayo Clinic review of patients' responses to a drug used to control nausea and vomiting during anesthesia for general surgery questions an FDA warning against the drug's use. This study appears in the current issue of the journal "Anesthesiology."
The FDA warning against droperidol was prompted in 2001 over concerns that the drug contributed to potentially fatal heart rhythm abnormalities. Mayo Clinic compared 139,932 patients' responses before the warning was issued (and droperidol was used) and found no proven cases of complications directly attributable to droperidol.
In contrast, after the FDA warning, two of 151,256 patients had poor heart rhythm ...